These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34242809)

  • 1. Can healthy lifestyle reduce disease progression of Alzheimer's during a global pandemic of COVID-19?
    John A; Ali K; Marsh H; Reddy PH
    Ageing Res Rev; 2021 Sep; 70():101406. PubMed ID: 34242809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
    Amadoro G; Latina V; Stigliano E; Micera A
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.
    Chen F; Chen Y; Wang Y; Ke Q; Cui L
    Transl Neurodegener; 2022 Sep; 11(1):40. PubMed ID: 36089575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome, Alzheimer's Disease, and Covid 19: A Possible Correlation.
    Finelli C
    Curr Alzheimer Res; 2021; 18(12):915-924. PubMed ID: 34886772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.
    Naughton SX; Raval U; Pasinetti GM
    J Alzheimers Dis; 2020; 76(1):21-25. PubMed ID: 32538855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.
    Chiricosta L; Gugliandolo A; Mazzon E
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and Alzheimer's Disease: A Literature Review.
    Hardan L; Filtchev D; Kassem R; Bourgi R; Lukomska-Szymanska M; Tarhini H; Salloum-Yared F; Mancino D; Kharouf N; Haikel Y
    Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic.
    Nawaz AD; Haider MZ; Akhtar S
    Biomol Biomed; 2024 Mar; 24(2):219-229. PubMed ID: 38078809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias.
    Brown EE; Kumar S; Rajji TK; Pollock BG; Mulsant BH
    Am J Geriatr Psychiatry; 2020 Jul; 28(7):712-721. PubMed ID: 32331845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.
    Sirin S; Nigdelioglu Dolanbay S; Aslim B
    J Neural Transm (Vienna); 2022 Jul; 129(7):847-859. PubMed ID: 35429259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the Potential Shared Molecular Mechanisms between COVID-19 and Alzheimer's Disease via Transcriptomic Analysis.
    Fan Y; Liu X; Guan F; Hang X; He X; Jin J
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and Alzheimer's disease: how one crisis worsens the other.
    Xia X; Wang Y; Zheng J
    Transl Neurodegener; 2021 Apr; 10(1):15. PubMed ID: 33941272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Links between COVID-19 and Alzheimer's Disease-What Do We Already Know?
    Rudnicka-Drożak E; Drożak P; Mizerski G; Zaborowski T; Ślusarska B; Nowicki G; Drożak M
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.
    Ding Q; Shults NV; Gychka SG; Harris BT; Suzuki YJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 as a Risk Factor for Alzheimer's Disease.
    Golzari-Sorkheh M; Weaver DF; Reed MA
    J Alzheimers Dis; 2023; 91(1):1-23. PubMed ID: 36314211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2023 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2023 Apr; 19(4):1598-1695. PubMed ID: 36918389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease in elderly COVID-19 patients: potential mechanisms and preventive measures.
    Wang H; Lu J; Zhao X; Qin R; Song K; Xu Y; Zhang J; Chen Y
    Neurol Sci; 2021 Dec; 42(12):4913-4920. PubMed ID: 34550494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
    Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection.
    Nuovo GJ; Suster D; Sawant D; Mishra A; Michaille JJ; Tili E
    Ann Diagn Pathol; 2022 Dec; 61():152057. PubMed ID: 36334414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spike Protein Fragments Promote Alzheimer's Amyloidogenesis.
    Cao S; Song Z; Rong J; Andrikopoulos N; Liang X; Wang Y; Peng G; Ding F; Ke PC
    ACS Appl Mater Interfaces; 2023 Aug; 15(34):40317-40329. PubMed ID: 37585091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.